Resultado da Busca
This “Metastatic Non-small Cell Lung Cancer - Market Insights, Epidemiology and Market Forecast - 2032” report delivers an in-depth understanding of top oncogenic drivers/biomarker in Non-small Cell Lung Cancer (such as EGFR, c-MET, ROS1, KRAS, ALK, BRAF, PD-L1, etc), historical and forecasted epidemiology as well as the Non-small Cell Lung Cancer market trends in the United States, EU4 ...
27 de mai. de 2023 · Cancer incidence trends. During 2015, there were a total of 20,798 patients with the index metastatic cancers studied in National Cancer Institute’s Surveillance, Epidemiology, and End Results ...
DelveInsight's "Metastatic Colorectal Cancer (mCRC)- Epidemiology Forecast-2032" report delivers an in-depth understanding of the mCRC, historical and forecasted epidemiology as well as the mCRC trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
DelveInsight's "Metastatic Colorectal Cancer (mCRC)- Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the mCRC, historical and forecasted epidemiology as well as the mCRC market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
16 de fev. de 2021 · Among people diagnosed with metastatic colorectal cancer, approximately 70% to 75% of patients survive beyond 1 year, 30% to 35% beyond 3 years, and fewer than 20% beyond 5 years from diagnosis. The primary treatment for unresectable metastatic CRC is systemic therapy (cytotoxic chemotherapy, biologic therapy such as antibodies to cellular growth factors, immunotherapy, and their combinations.)
This section focusses on the rate of uptake of the potential drugs recently launched in the Colorectal Cancer market or expected to get launched in the market during the study period 2019-2032. The analysis covers Colorectal Cancer market uptake by drugs; patient uptake by therapies; and sales of each drug. This helps in understanding the drugs ...
9 de mai. de 2024 · 3 Market Competition, by Players 3.1 Global Metastatic Colorectal Cancer Treatment Revenue and Share by Players (2019,2020,2021,2022,2023 and 2024) 3.2 Market Concentration Rate 3.2.1 Top3 ...
